Roivant Sciences (NASDAQ:ROIV) Earns “Buy” Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. They currently have a $18.00 price target on the stock. Separately, Cantor Fitzgerald raised Roivant Sciences to a “strong-buy” rating in a research note on Tuesday, March 4th. View Our […]
HC Wainwright reaffirmed their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research report sent to investors on Wednesday,Benzinga reports. They currently have a $18.00 price target on the stock. Separately, Cantor Fitzgerald raised Roivant Sciences to a “strong-buy” rating in a research note on Tuesday, March 4th. View Our […]
